Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $39.5400 (-5.23%) ($37.0500 - $41.2000) on Mon. Dec. 17, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.03% (three month average) | RSI | 55 | Latest Price | $39.5400(-5.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.6% a day on average for past five trading days. | Weekly Trend | ATRA advances 2.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(58%) ARKG(51%) IBB(50%) IWO(50%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -2.015% in a week (0% probabilities). VXX(-14%) TLT(-14%) VIXM(-13%) UUP(-11%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.015% (StdDev 4.03%) | Hourly BBV | 0 () | Intraday Trend | -4% | | | |
|
Resistance Level | $39.93 | 5 Day Moving Average | $41.74(-5.27%) | 10 Day Moving Average | $41.45(-4.61%) | 20 Day Moving Average | $39.93(-0.98%) | To recent high | -9.1% | To recent low | 25.1% | Market Cap | $2.938b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |